************************ IPREX STUDY ON AIDS PREVENTION**********************
According to this study, an anti-retroviral pill--Truvada, a combination of two drugs, tenofovir and emtricitabine--helps prevent AIDS. The study, nicknamed iPrEx, included nearly 2,500 men in six countries and was co-ordinated by the Gladstone Institutes of the University of California, San Francisco. The results are better than the results made public in the summer of 2010 that a vaginal microbicide had protected 39% of all the women testing it and 54% of those who had used it faithfully.
Source: The Dallas Morning News (November 24, 2010)
Source: The Dallas Morning News (November 24, 2010)
************************ IPREX STUDY ON AIDS PREVENTION**********************
The biennial world conference on AIDS returned this year to Washington as approximately 20,000 scientists, doctors, policy-makers and patients gathered for a week-long discussion and debate on the latest curse on mankind. The International AIDS Society-organized conference began on July 22, 2012. The fight against HIV has taken a backseat in recent years because of global financial distrait and complacency. Last year (2011), $16.8 billion was spent on HIV prevention in poor countries that had enabled eight million HIV patients to be accepted for treatment. An additional $7 billion funding is needed to provide access to 15 million people who will need the most by 2015. At present, 34.2 million live with HIV, and the International AIDS Society President Dr. Elly Katabira promised on the opening day (July 22, 2012) of the International AIDS Conference that the world "must resolve together never to go backwards". Even in the USA, 50,000 new cases of HIV are reported every year over the past several years, and 1.2 million people live with HIV with one-fifth not knowing about it.
Dallas to Join Fast-Track Cities Initiative
Dallas and surrounding cities will announce on August 26, 2019 that they are joining the Fast-Track Cities, an international campaign to end the HIV epidemic by 2030, according to an August 24, 2019, published report carried by The Dallas Morning News. The trio of tenets of the Fast-Track Cities are 90-90-90 rules, implying 90% of the people with HIV to be diagnosed and 90% of the diagnosed to be treated with anti-retroviral therapy to suppress the disease for 90% of the patients under therapy. After years of dramatic improvement, fight against HIV infection had stalled in recent years, according to a 2013 CDC report. Community activists in Dallas County are trying to reach out to the target population to urge them to take PrEP, or Pre-Exposure Prophylaxis, if they are at risk of infecting HIV and PEP, or Post-Exposure Prophylaxis, within 72 hours of infecting.
Dallas to Join Fast-Track Cities Initiative
Dallas and surrounding cities will announce on August 26, 2019 that they are joining the Fast-Track Cities, an international campaign to end the HIV epidemic by 2030, according to an August 24, 2019, published report carried by The Dallas Morning News. The trio of tenets of the Fast-Track Cities are 90-90-90 rules, implying 90% of the people with HIV to be diagnosed and 90% of the diagnosed to be treated with anti-retroviral therapy to suppress the disease for 90% of the patients under therapy. After years of dramatic improvement, fight against HIV infection had stalled in recent years, according to a 2013 CDC report. Community activists in Dallas County are trying to reach out to the target population to urge them to take PrEP, or Pre-Exposure Prophylaxis, if they are at risk of infecting HIV and PEP, or Post-Exposure Prophylaxis, within 72 hours of infecting.
************************** PEPFAR
Renewal of PEPFAR at Crosshairs of Partisan Battle
A successful program that had saved millions of people's lives in more than 50 nations across the globe and brought so much of political goodwill for the U.S. recently fell victim to partisan political bickering and GOP blackmail. The program, President's Emergency Plan for AIDS Relief, or PEPFAR, according to the July 31, 2023, edition of The Dallas Morning News, has invested more than $100 billion since its inception in 2003 and has been renewed three times with a five-year mandate each time. The current five-year term will expire on September 30, 2023, and the Congress is not even close to opening a meaningful negotiation to extend the program for another five years. The main contention is related to the Republican allegation--many health experts and PEPFAR groups call that sham at best and cynical at its worst--that PEPFAR funding is being diverted to fund abortions overseas. A New Jersey Republican member of the House, Rep. Christopher Smith, a key House panel chairman, shifted his stance over PEPFAR after a May 2023 Heritage Foundation report alleged abortion connection to PEPFAR funding and anti-abortion groups such as Heritage, Susan B. Anthony Pro-Life America and Family Research Council subsequently began to put pressure on Republican members not to renew the PEPFAR funding. A middle-ground of extending the PEPFAR funding for one year is being discussed too, but the White House insists that a clean bill of five-year extension is the one that it is looking forward to from the Congress.
************************** PEPFAR
No comments:
Post a Comment